Injectable disease modifying agents in multiple sclerosis: pattern of medication use and clinical effectiveness
The objective of this study was to assess long-term use, adherence and efficacy of injectable disease modifying agents (DMAs). Multiple Sclerosis (MS) patients diagnosed during 2002-2010 with early treatment start and at least one year in first choice medication were included in a large university d...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2016-09-01
|
| Col·lecció: | Neurology International |
| Matèries: | |
| Accés en línia: | http://www.pagepress.org/journals/index.php/ni/article/view/6513 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|